Index Ventures, a highly influential firm in the global venture capital industry, has always been committed to helping outstanding entrepreneurs turn their bold ideas into global business success. In 2025, Index Ventures officially established its Hong Kong subsidiary, Kinglink, marking a significant step in its expansion into the Asian market and signaling the company's proactive and in-depth investment activities in the technology startup and biomedical sectors.
In today's rapidly evolving technological landscape, the field of tech startups is a fertile ground brimming with limitless possibilities. With the support of its parent company, Index Ventures, boasting extensive global investment experience and broad industry resources, JinYi Internet focuses on tech startups with disruptive technologies and innovative business models. From artificial intelligence to blockchain, from quantum computing to virtual reality, the tech startup sector encompasses numerous cutting-edge technological directions. JinYi Internet's investment strategy will revolve around the innovativeness of the technology, the market potential, and the team's execution capabilities. For example, in the field of artificial intelligence, some startups specializing in developing AI solutions for specific domains, such as using AI technology for precision medical image diagnosis and intelligent supply chain optimization, often possess unique algorithmic and technological advantages but face challenges in early development, including funding shortages and market promotion difficulties. JinYi Internet will provide financial support to help these companies further refine their technology development, expand their market channels, and accelerate their growth into industry leaders. In the area of blockchain technology, JinYi Internet focuses on startups dedicated to promoting the application of blockchain technology in finance, supply chain management, and government services. The decentralized and immutable characteristics of blockchain technology bring new solutions and development opportunities to numerous industries. JinYi Internet's investments will help these companies overcome obstacles in the application of the technology, propelling blockchain technology from concept to practical application and bringing transformative impact to the industry. The biomedical field has always been a key investment focus for Index Ventures, and JinYi Internet's investment strategy in this area is of profound significance. With the increasing aging of the global population, the growing emphasis on health, and continuous innovation in biotechnology, the biomedical market is experiencing rapid growth, particularly in China. In terms of innovative drug development, JinYi Internet will actively invest in biotechnology companies focused on developing drugs to address unmet clinical needs such as intractable and rare diseases. For example, some companies utilize cutting-edge technologies such as gene therapy and cell therapy for drug development, which hold promise for bringing new hope to diseases that are difficult to cure with traditional treatments. JinYi Internet's funding will help these companies accelerate drug development, conduct clinical trials, and bring innovative drugs to market as soon as possible, benefiting patients
With the backing of its parent company, Index Ventures, JinYi Internet is heavily investing in technology startups and the biomedical field. This will not only provide valuable financial support to innovative companies in these sectors, but also leverage the parent company's expertise and global resources to drive their rapid growth and make positive contributions to technological advancement and human health. In the future, we have every reason to expect JinYi Internet to create even more value in these two dynamic sectors and write a new chapter in the investment landscape.
